Serotonin (5-hydroxytryptamine) in medullary thyroid carcinoma with or without pheochromocytoma
- 15 April 1985
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 21 (4) , 469-473
- https://doi.org/10.1016/0277-5379(85)90039-2
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Familial medullary thyroid carcinoma in multiple endocrine neoplasia (MEN) IIa: Diagnosis and problems in treatmentEuropean Journal of Cancer and Clinical Oncology, 1982
- The Prognostic and Biological Significance of Cellular Heterogeneity in Medullary Thyroid Carcinoma: A Study of Calcitonin, L-Dopa Decarboxylase, and Histaminase*Journal of Clinical Endocrinology & Metabolism, 1982
- Human pharmacokinetics of long term 5-hydroxytryptophan combined with decarboxylase inhibitorsEuropean Journal of Clinical Pharmacology, 1982
- Radioimmunoassay of calcitonin in unextracted human serum: A sensitive methodScandinavian Journal of Clinical and Laboratory Investigation, 1982
- Radioenzymatic assay of platelet serotonin, dopamine and norepinephrine in subjects with normal and increased serotonin productionClinica Chimica Acta; International Journal of Clinical Chemistry, 1981
- The Relationship between Enzyme Activity and the Catecholamine Content and Secretion of Pheochromocytomas*Journal of Clinical Endocrinology & Metabolism, 1979
- Serotonin metabolism and platelet monoamine oxidase activity in patients with medullary carcinoma of the thyroid and pheochromocytomaThe Lancet Healthy Longevity, 1979
- Dopa Decarboxylase in Medullary Carcinoma of the ThyroidNew England Journal of Medicine, 1973
- Diarrhea and medullary carcinoma of the thyroidCancer, 1973
- ON THE OCCURRENCE OF MONOAMINES AND RELATED SUBSTANCES IN FAMILIAL MEDULLARY THYROID CARCINOMA WITH PHAEOCHROMOCYTOMAActa Pathologica Microbiologica Scandinavica, 1968